SeaBridge Investment Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-50
Closed -$13K 167
2020
Q3
$13K Buy
+50
New +$13.5K ﹤0.01% 226
2018
Q2
Sell
-135
Closed -$30K 254
2018
Q1
$30K Sell
135
-150
-53% -$35.2K 0.01% 181
2017
Q4
$64K Hold
285
0.01% 161
2017
Q3
$54K Sell
285
-365
-56% -$69.5K 0.01% 167
2017
Q2
$122K Hold
650
0.03% 156
2017
Q1
$107K Sell
650
-95
-13% -$15.1K 0.03% 158
2016
Q4
$107K Hold
745
0.03% 158
2016
Q3
$93K Hold
745
0.02% 154
2016
Q2
$98K Buy
+745
New +$102K 0.02% 157

Other funds holding ELV

SeaBridge Investment Advisors's ELV Position: Q4 2020 in Review

SeaBridge Investment Advisors sold out of Elevance Health (ELV) in Q4 2020, closing a stake of 50 shares — an estimated $13K sold.

SeaBridge Investment Advisors first reported a position in ELV in Q2 2016 and held it in 9 quarters. The position peaked at $122K in Q2 2017. 1,170 funds tracked by Wall St. Rank hold ELV as of Q4 2020.

  • SeaBridge Investment Advisors reported no remaining Elevance Health position as of Q4 2020 after selling out during the quarter.
  • SeaBridge Investment Advisors sold 50 Elevance Health shares in Q4 2020, an estimated $13K.
  • SeaBridge Investment Advisors first reported a position in Elevance Health in Q2 2016 and held it in 9 quarters.
  • SeaBridge Investment Advisors's Elevance Health position peaked at $122K in Q2 2017.
  • 1,170 funds tracked by Wall St. Rank held Elevance Health as of Q4 2020.

Based on SeaBridge Investment Advisors's 13F filing for Q4 2020, filed 9 Feb 2021.